ABT-874 versus etanercept and placebo in patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results

被引：0
|
作者：
Strober, Bruce [1 ]
Crowley, Jeffrey [2 ]
Valdes, Joaquin [3 ]
Gu, Yihua [3 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] Bakersfield Dermatol, Bakersfield, CA USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2011年 / 64卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB155 / AB155
页数：1
相关论文
共 50 条
  • [41] Maintenance of efficacy and safety with continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: Final phase IIIb study results
    Gottlieb, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P1 - P1
  • [42] Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: 52-Week Results
    Yoshinori Umezawa
    Akihiko Asahina
    Shinichi Imafuku
    Yayoi Tada
    Shigetoshi Sano
    Akimichi Morita
    Shinya Sakurai
    Naoki Hoshii
    Nicola Tilt
    Hidemi Nakagawa
    Dermatology and Therapy, 2021, 11 : 943 - 960
  • [43] Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: 52-Week Results
    Umezawa, Yoshinori
    Asahina, Akihiko
    Imafuku, Shinichi
    Tada, Yayoi
    Sano, Shigetoshi
    Morita, Akimichi
    Sakurai, Shinya
    Hoshii, Naoki
    Tilt, Nicola
    Nakagawa, Hidemi
    DERMATOLOGY AND THERAPY, 2021, 11 (03) : 943 - 960
  • [44] Modeling the exposure-response relationship of etanercept in the treatment of patients with chronic moderate to severe plaque psoriasis
    Hutmacher, Matthew M.
    Nestorov, Ivan
    Ludden, Tom
    Zitnik, Ralph
    Banfield, Christopher
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (02): : 238 - 248
  • [45] Etanercept in patients with moderate to severe plaque psoriasis: a retrospective case cohort analysis
    Perera, G.
    Fonia, A.
    Smith, C.
    Barker, J. N. W. N.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 : 26 - 27
  • [46] Long-term safety and efficacy of adalimumab in the treatment of moderate to severe chronic plaque psoriasis
    Langley, R
    Leonardi, C
    Toth, D
    Chen, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P2 - P2
  • [47] A Comparative Study of the Efficacy of Methotrexate versus Methotrexate with Apremilast in Moderate to Severe Chronic Plaque Psoriasis
    Srivastava, Divyanshu
    Krishna, Arvind
    David, Abhinav
    INDIAN JOURNAL OF DERMATOLOGY, 2023, 68 (04) : 393 - 398
  • [48] Safety and tolerability of extended efalizumab therapy in patients with chronic moderate to severe plaque psoriasis
    Gottlieb, A
    Hamilton, T
    Rafal, E
    Caro, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB11 - AB11
  • [49] Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
    Chan, Wai Sze Agnes
    Wong, Yisheng
    Oon, Hazel Hwee Boon
    Theng, Colin Thiam Seng
    Chong, Wei-Sheng
    SINGAPORE MEDICAL JOURNAL, 2023, 64 (07) : 434 - 438
  • [50] Effectiveness and safety of secukinumab in patients with moderate to severe plaque psoriasis
    Moron, R.
    Alvarez, R.
    Nieto, P.
    Garcia, C.
    Belda, S.
    Cabeza, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 378 - 378
12345